|
|
|
|
|
|
| Open:
|
15.62 |
|
Volume:
|
5461 |
| High:
|
16.11 |
|
52Wk High:
|
35.65 |
| Low:
|
14.42 |
|
52Wk Low:
|
2.41 |
|
|
|
|
|
|
|
|
|
|
|
15 Skyline Drive
Hawthorne, NY 10532, US
|
|
Russell 2000
Biological Products, Except Diagnostic Substances |
| |
|
|
|
 |
 |
|
 |
|
Free Registration enables all site features including Email Alerts, RSS Feeds, Charts & Reports, SEC Filings, and Executive & Company Profiles.
|
 |
 |
 |
 |
|
|
 |
|
 |
|
|
|
|
Board Member Report includes all current and historical board members, their board committees, whether they are the chair of each committee, the date they became a member of the board and their Job Title if they are also an executive of the firm. Also, you can create an email alert for any board member right from the Board Member report!
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEC filings are made available through
SECFilings.com – our free SEC filings portal with e-mail alert
and RSS capabilities. Clicking on the links to the left will bring you to the
corresponding page on SECFilings.com where you can login with your
ExecutiveDisclosure.com username and password to instantly view filings and
setup e-mail or RSS alerts.
|
|
 |
 |
 |
|
|
|
|
Company Average Compensation vs. Average Compensation for all Same Market Cap Companies in Same Industry chart compares the average pay for the company against all companies in the same industry and market cap using actual dollar figures.
|
|
|
|
|
|
 |
|
 |
|
|
 |
|
|
|
|
Company Average Compensation vs. Industry Average Compensation chart compares the average pay for the company against all companies in the same industry using actual dollar figures, making it easy to see how the current company's compensation practices compare against the industry average.
|
|
|
|
|
|
|
|
|
|
|
|
Company Average Compensation % Trend vs. Company Stock Prices % Trend chart compares the year over year percentage change in the average compensation package against the year over year percentage change in the company's stock price.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| Sandra Panem, Ph.D., has been a member of our Board since 1998. She is currently a partner at Cross Atlantic Partners, which she joined in 2000. From 1994 to 1999, Dr. Panem was President of Vector Fund Management, the then asset management... (Read
more) |
|
1998
|
|
|
|
|
| |
|
|
|
|
| Ron Cohen, M.D., has served as our President and Chief Executive Officer since he founded Acorda in 1995. Dr. Cohen previously was a principal in the startup of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human... (Read
more) |
|
1995
1995
630000.00 |
|
|
|
|
| |
|
|
|
|
| Andrew R. Blight, Ph.D., has been our Chief Scientific Officer since January 2004 and previously served as our Executive Vice President, Research and Development from 2000 to 2004, and Vice President, Research and Development, from 1998 to 2000.... (Read
more) |
|
1998
335622.00 |
|
|
|
|
| |
|
|
|
|
| Mary Fisher has been our Chief Operating Officer since January 2005 and previously served as our Vice President, Commercial Operations from 2003 through 2004 and Vice President, Marketing and Strategic Planning from 2000 to 2003. From 1999 to 2000,... (Read
more) |
|
2000
161222.00 |
|
|
|
|
| |
|
|
|
|
| Jane Wasman, J.D., has been our Executive Vice President, General Counsel and Corporate Secretary since May 2004. From 1995 to 2004, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and... (Read
more) |
|
05/2004
351000.00 |
|
|
| | |